查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917892

药物滥用治疗市场－2026-2031年预测

Substance Abuse Treatment Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计药物滥用治疗市场将从 2025 年的 168.85 亿美元成长到 2031 年的 254.55 亿美元，复合年增长率为 7.08%。

药物滥用治疗市场是医疗保健系统中重要且不断增长的组成部分，它透过持续的医疗、行为和社会心理干预来应对成瘾这一复杂挑战。该市场涵盖广泛的服务，包括戒毒、药物辅助性治疗(MAT)、住院和门诊康復、咨询以及长期康復支持。推动其成长的因素包括：物质使用障碍 (SUD) 的持续高发生率、阿片类药物成瘾持续的公共卫生危机、循证治疗标准的不断发展，以及对以患者为中心的综合护理模式的日益重视，这些模式旨在解决成瘾的多方面问题。

推动市场扩张的一个根本且强大的因素是全球物质使用障碍的高发生率及其持续成长。对鸦片类药物、酒精、兴奋剂和其他物质的依赖造成了严重的公共卫生负担，导致发病率和死亡率上升，并带来巨大的社会经济成本。受影响人群的庞大规模使得对便捷有效的治疗服务的需求持续增长。公众和政府日益增强的意识进一步推动了这一需求，他们认识到成瘾是一种慢性、可治疗的疾病，而非道德缺陷。这减少了社会歧视，并鼓励更多人寻求帮助。

持续不断的鸦片危机，尤其是在北美地区，已成为推动市场关注和创新的实际而深远的催化剂。这场危机凸显了有效治疗方法的迫切性，并促成了重大的政策变革、资金分配和临床措施。这显着扩大了药物辅助性治疗（MAT）的普及和应用。 MAT将FDA认证核可药（例如Buprenornhine、美沙酮和纳曲酮）与咨商和行为疗法结合。 MAT被公认为鸦片类药物使用障碍治疗的黄金标准，其广泛应用是治疗市场发展的驱动力，有助于提高治疗依从性并降低致命性过量用药的风险。

同时，实证治疗方法的普及和完善正在重塑市场格局。该领域正从传统的「一刀切」式方法转向临床研究中已证实有效的干预措施。这包括认知行为疗法（CBT）、紧急管理和动机式访谈等特定行为疗法，这些疗法已被证明能有效减少物质滥用并预防復发。将这些实证实践融入标准治疗通讯协定，不仅能改善患者预后，还能确保获得保险报销，并在医疗服务网络中建立更高的护理标准。

一个关键趋势是转向全面、个人化的照护模式，将成瘾视为一种生物心理社会疾病。有效的治疗现在通常同时关注共存的精神疾病（双重诊断）、潜在创伤、社会健康决定因素以及整体健康状况。这种综合办法需要一个由医生、精神科医生、治疗师和社会工作者组成的多学科团队来制定个人化的治疗方案。这种关注“整体治疗”，而不仅仅是治疗成瘾，可以提高患者的参与度、治疗依从性和长期康復成功率，也是高品质医疗机构之间的关键区别所在。

从地理位置来看，北美在市场上占据主导地位。这项优势归功于物质使用疾患（SUDs）的高发生率，尤其是阿片类药物使用疾患；相对完善的治疗基础设施；大量的公共和私人资金投入成瘾服务；以及逐步支持扩大药物辅助性治疗（MAT）覆盖法规环境。专业治疗机构的集中以及为应对成瘾危机而持续推出的政策倡议，进一步巩固了该地区的核心地位。

服务模式涵盖不同程度的护理，以满足不同程度的病情和患者的需求。这些模式包括医疗监管下的住院戒毒、强化型住宅復健、部分住院治疗项目（PHP）、强化门诊治疗计画（IOP）以及标准门诊咨询。目前的趋势是建立一个整合的连续性照护体系，允许在患者的整个治疗过程中逐步调整治疗强度，从而提高照护的连续性，并减少可能导致復发的服务缺口。

竞争格局包括专注于行为健康的上市大规模医疗保健机构、全国性非营利治疗组织以及众多区域性和地方性诊所。关键竞争因素包括临床品质和治疗效果、认证状态、提供全面双重诊断护理的能力、医保网络覆盖范围以及提供全面服务系统的能力。策略性成长通常包括併购和联盟，以扩大地域覆盖范围和服务能力。

总之，为因应严峻且持续的公共卫生需求，药物滥用治疗市场不断发展演变。其成长动力源自于成瘾流行、鸦片类药物危机的特异性性以及更有效、更人性化、更全面的照护模式的日益成熟。未来市场发展将受到以下因素的影响：进一步将成瘾治疗融入主流医疗保健体系；解决合格临床医生短缺问题；克服服务不足地区的就医障碍；以及确保循证服务的永续报销。这一市场发展轨迹体现了社会对为慢性病患者提供有效且有尊严的护理，以及帮助个人和社区恢復健康、功能和希望的坚定承诺。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
  • 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议：利用这些见解，在快速变化的环境中製定策略决策，发展新的商业机会和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

您打算如何使用这份报告？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 按物质类型分類的药物滥用治疗市场

  • 介绍
  • 酒精
  • 阿片类药物
  • 大麻
  • 其他的

6. 按治疗类型分類的药物滥用治疗市场

  • 介绍
  • 行为疗法
  • 药物辅助治疗（MAT）
  • 戒毒疗法
  • 其他的

7. 按应用分類的药物滥用治疗市场

  • 介绍
  • 住院设施
  • 门诊设施

8. 各地区的药物滥用治疗市场

  • 介绍
  • 北美洲
    • 药物
    • 按治疗类型
    • 透过使用
    • 按国家/地区
      • 我们
      • 加拿大
      • 墨西哥
  • 南美洲
    • 药物
    • 按治疗类型
    • 透过使用
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 药物
    • 按治疗类型
    • 透过使用
    • 按国家/地区
      • 德国
      • 法国
      • 英国
      • 西班牙
      • 义大利
      • 其他的
  • 中东和非洲
    • 药物
    • 按治疗类型
    • 透过使用
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 药物
    • 按治疗类型
    • 透过使用
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 印尼
      • 泰国
      • 台湾
      • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Acadia Healthcare Company, Inc.
  • Hazelden Betty Ford Foundation
  • Promises Behavioral Health
  • Caron Treatment Center
  • Behavioral Health Group（Bhg）
  • Crossroads Treatment Centers
  • Sandstone Care
  • American Addiction Centers, Inc.
  • Mayo Clinic
  • Pelago

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615957

Substance Abuse Treatment Market is projected to expand at a 7.08% CAGR, attaining USD 25.455 billion in 2031 from USD 16.885 billion in 2025.

The substance abuse treatment market is a critical and expanding segment of the global healthcare system, dedicated to addressing the complex challenges of addiction through a continuum of medical, behavioral, and psychosocial interventions. This market encompasses a wide range of services, including detoxification, medication-assisted treatment (MAT), inpatient and outpatient rehabilitation, counseling, and long-term recovery support. Its growth is driven by the persistent and rising prevalence of substance use disorders (SUDs), the ongoing public health crisis of opioid addiction, evolving evidence-based treatment standards, and an increasing emphasis on holistic, patient-centered care models that address the multifaceted nature of addiction.

A fundamental and powerful driver of market expansion is the high and increasing global prevalence of substance use disorders. Addiction to opioids, alcohol, stimulants, and other substances represents a significant burden on public health, contributing to morbidity, mortality, and substantial socioeconomic costs. The sheer scale of affected individuals creates a sustained and growing demand for accessible, effective treatment services. This demand is further intensified by heightened public and governmental awareness of addiction as a chronic, treatable medical condition rather than a moral failing, which is reducing stigma and encouraging more individuals to seek help.

The ongoing opioid epidemic, particularly in North America, represents a specific and acute catalyst for market focus and innovation. The crisis has underscored the urgent need for effective treatment modalities and has driven significant policy changes, funding allocations, and clinical initiatives. This has led to a substantial expansion in the availability and utilization of medication-assisted treatment (MAT), which combines FDA-approved medications (such as buprenorphine, methadone, and naltrexone) with counseling and behavioral therapies. MAT is recognized as the gold standard for opioid use disorder, and its broader adoption is a major factor propelling the treatment market forward, improving retention in care and reducing the risk of fatal overdose.

Parallel to this, the market is being shaped by the widespread adoption and refinement of evidence-based treatment modalities. The field is moving beyond traditional, one-size-fits-all approaches toward interventions with demonstrated efficacy in clinical research. This includes specific behavioral therapies like cognitive-behavioral therapy (CBT), contingency management, and motivational interviewing, which are proven to reduce substance use and prevent relapse. The integration of these evidence-based practices into standard treatment protocols is improving patient outcomes, justifying reimbursement, and establishing higher standards of care across provider networks.

A significant trend is the shift toward holistic and individualized care models that recognize addiction as a biopsychosocial disorder. Effective treatment now routinely addresses co-occurring mental health conditions (dual diagnosis), underlying trauma, social determinants of health, and overall wellness. This comprehensive approach involves multidisciplinary teams of physicians, psychiatrists, therapists, and social workers creating personalized treatment plans. The focus on treating the whole person-not just the addiction-improves engagement, treatment retention, and long-term recovery success, making it a key differentiator for high-quality providers.

Geographically, North America maintains a dominant position in the market. This leadership is attributed to a high prevalence of SUDs, particularly opioid use disorder; a relatively well-developed treatment infrastructure; significant public and private funding for addiction services; and a regulatory environment that has progressively supported the expansion of treatment access, especially for MAT. The region's concentration of specialized treatment centers and ongoing policy initiatives to combat the addiction crisis further solidify its central role.

The service delivery model spans various levels of care to match patient acuity and need. This includes medically managed inpatient detoxification, residential rehabilitation for intensive therapy, partial hospitalization programs (PHP), intensive outpatient programs (IOP), and standard outpatient counseling. The trend is toward creating integrated care continua that allow patients to step up or down in intensity based on their progress, improving continuity of care and reducing gaps in service that can lead to relapse.

The competitive landscape includes large publicly traded healthcare providers specializing in behavioral health, national non-profit treatment organizations, and a vast number of local and regional clinics. Key competitive factors include clinical quality and outcomes, accreditation, the ability to provide integrated dual diagnosis care, payer network coverage, and the capacity to offer a full continuum of services. Strategic growth often involves mergers, acquisitions, and partnerships to expand geographic reach and service capabilities.

In conclusion, the substance abuse treatment market is evolving in response to a profound and persistent public health need. Its growth is fueled by the escalating prevalence of addiction, the specific urgency of the opioid crisis, and the maturation of more effective, compassionate, and comprehensive care models. Future market development will be shaped by efforts to further integrate addiction treatment into mainstream healthcare, address workforce shortages of qualified clinicians, overcome barriers to access in underserved areas, and secure sustainable reimbursement for evidence-based services. The market's trajectory reflects a critical societal effort to provide effective, dignified care for a chronic condition, with the goal of restoring health, function, and hope to individuals and communities.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Substance Abuse Treatment Market Segmentation

  • By Substance
  • Alcohol
  • Opioids
  • Marijuana
  • Others
  • By Treatment Type
  • Behavioral Therapy
  • Medication-Assisted Treatment (MAT)
  • Detoxification
  • Others
  • By Application
  • In-Patient Facility
  • Outpatient Facility
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SUBSTANCE ABUSE TREATMENT MARKET BY SUBSTANCE

  • 5.1. Introduction
  • 5.2. Alcohol
  • 5.3. Opioids
  • 5.4. Marijuana
  • 5.5. Others

6. SUBSTANCE ABUSE TREATMENT MARKET BY TREATMENT TYPE

  • 6.1. Introduction
  • 6.2. Behavioral Therapy
  • 6.3. Medication-Assisted Treatment (MAT)
  • 6.4. Detoxification
  • 6.5. Others

7. SUBSTANCE ABUSE TREATMENT MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. In-Patient Facility
  • 7.3. Outpatient Facility

8. SUBSTANCE ABUSE TREATMENT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Substance
    • 8.2.2. By Treatment Type
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Substance
    • 8.3.2. By Treatment Type
    • 8.3.3. By Application
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Substance
    • 8.4.2. By Treatment Type
    • 8.4.3. By Application
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Spain
      • 8.4.4.5. Italy
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Substance
    • 8.5.2. By Treatment Type
    • 8.5.3. By Application
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Substance
    • 8.6.2. By Treatment Type
    • 8.6.3. By Application
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. India
      • 8.6.4.3. Japan
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Acadia Healthcare Company, Inc.
  • 10.2. Hazelden Betty Ford Foundation
  • 10.3. Promises Behavioral Health
  • 10.4. Caron Treatment Center
  • 10.5. Behavioral Health Group (Bhg)
  • 10.6. Crossroads Treatment Centers
  • 10.7. Sandstone Care
  • 10.8. American Addiction Centers, Inc.
  • 10.9. Mayo Clinic
  • 10.10. Pelago

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations